Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Pancreatitis

Free Subscription Articles published in Gut Retrieve available abstracts of 100 articles: HTML format

Single Articles

April 2024
1. 
   Correction: Identification of c-FLIPL and c-FLIPS as critical regulators of death receptor-induced apoptosis in pancreatic cancer cells.
   Gut. 2024;73:e8.
   PubMed    
   
   
   March 2024
2. WANG YC, Mao XT, Sun C, Wang YH, et al
   Pancreas-directed AAV8-hSPINK1 gene therapy safely and effectively protects against pancreatitis in mice.
   Gut. 2024 Mar 29:gutjnl-2023-330788. doi: 10.1136/gutjnl-2023-330788.
   PubMed     Abstract available
   
   
   
3. GUNJAN D, Mahapatra SJ, Garg PK
   Is acute necrotising pancreatitis a chronic disease?
   Gut. 2024 Mar 26:gutjnl-2024-331915. doi: 10.1136/gutjnl-2024-331915.
   PubMed    
   
   
   
4. AMMER-HERRMENAU C, Neesse A
   Response to: short-chain fatty acids in patients with severe acute pancreatitis: friend or foe?
   Gut. 2024 Mar 7:gutjnl-2024-332236. doi: 10.1136/gutjnl-2024-332236.
   PubMed    
   
   
   
5. PUST MM, Rocha Castellanos DM, Rzasa K, Dame A, et al
   Absence of a pancreatic microbiome in intraductal papillary mucinous neoplasm.
   Gut. 2024 Mar 1:gutjnl-2023-331012. doi: 10.1136/gutjnl-2023-331012.
   PubMed     Abstract available
   
   
   February 2024
6. VAN DEN BERG FF, Besselink MG, van Santvoort H
   Short-chain fatty acids in patients with severe acute pancreatitis: friend or foe?
   Gut. 2024 Feb 15:gutjnl-2024-332129. doi: 10.1136/gutjnl-2024-332129.
   PubMed    
   
   
   January 2024
7. HOLLEMANS RA, Timmerhuis HC, Besselink MG, Bouwense SAW, et al
   Long-term follow-up study of necrotising pancreatitis: interventions, complications and quality of life.
   Gut. 2024 Jan 24:gutjnl-2023-329735. doi: 10.1136/gutjnl-2023-329735.
   PubMed     Abstract available
   
   
   
8. TONELLI C, Yordanov GN, Hao Y, Deschenes A, et al
   A mucus production programme promotes classical pancreatic ductal adenocarcinoma.
   Gut. 2024 Jan 23:gutjnl-2023-329839. doi: 10.1136/gutjnl-2023-329839.
   PubMed     Abstract available
   
   
   
9. SABA E, Farhat M, Daoud A, Khashan A, et al
   Oral bacteria accelerate pancreatic cancer development in mice.
   Gut. 2024 Jan 17:gutjnl-2023-330941. doi: 10.1136/gutjnl-2023-330941.
   PubMed     Abstract available
   
   
   
10. KWAN MC, Pitman MB, Fernandez-Del Castillo C, Zhang ML, et al
    Revisiting the performance of cyst fluid carcinoembryonic antigen as a diagnostic marker for pancreatic mucinous cysts: a comprehensive 20-year institutional review.
    Gut. 2024 Jan 9:gutjnl-2023-331138. doi: 10.1136/gutjnl-2023-331138.
    PubMed     Abstract available
    
    
    December 2023
11. AMMER-HERRMENAU C, Antweiler KL, Asendorf T, Beyer G, et al
    Gut microbiota predicts severity and reveals novel metabolic signatures in acute pancreatitis.
    Gut. 2023 Dec 21:gutjnl-2023-330987. doi: 10.1136/gutjnl-2023-330987.
    PubMed     Abstract available
    
    
    
12. BEN-AMI R, Wang QL, Zhang J, Supplee JG, et al
    Protein biomarkers and alternatively methylated cell-free DNA detect early stage pancreatic cancer.
    Gut. 2023 Dec 13:gutjnl-2023-331074. doi: 10.1136/gutjnl-2023-331074.
    PubMed     Abstract available
    
    
    
13. HANNEMANN A, Mayerle J, Beyer G
    Response to: Correspondence on 'Definition of age-dependent reference values for the diameter of the common bile duct and pancreatic duct on MRCP: still needed further discussion' by Wang et al.
    Gut. 2023 Dec 2:gutjnl-2023-331525. doi: 10.1136/gutjnl-2023-331525.
    PubMed    
    
    
    October 2023
14. SANDOR M, Sahin-Toth M
    Functional predictors of pathogenicity of missense CPA1 variants in chronic pancreatitis.
    Gut. 2023 Oct 19:gutjnl-2023-331105. doi: 10.1136/gutjnl-2023-331105.
    PubMed    
    
    
    
15. WANG F, Peng L, Liu Y
    Definition of age-dependent reference values for the diameter of the common bile duct and pancreatic duct on MRCP: still needed further discussion.
    Gut. 2023 Oct 10:gutjnl-2023-331163. doi: 10.1136/gutjnl-2023-331163.
    PubMed    
    
    
    
16. MICHL P, Roth L
    Female advantage in neoadjuvant pancreatic cancer therapy: is it down to macrophages?
    Gut. 2023 Oct 9:gutjnl-2023-330830. doi: 10.1136/gutjnl-2023-330830.
    PubMed    
    
    
    September 2023
17. VAN EIJCK CWF, Mustafa DAM, Vadgama D, de Miranda NFCC, et al
    Enhanced antitumour immunity following neoadjuvant chemoradiotherapy mediates a favourable prognosis in women with resected pancreatic cancer.
    Gut. 2023 Sep 14:gutjnl-2023-330480. doi: 10.1136/gutjnl-2023-330480.
    PubMed     Abstract available
    
    
    
18. WU Y, Seufert I, Al-Shaheri FN, Kurilov R, et al
    DNA-methylation signature accurately differentiates pancreatic cancer from chronic pancreatitis in tissue and plasma.
    Gut. 2023 Sep 14:gutjnl-2023-330155. doi: 10.1136/gutjnl-2023-330155.
    PubMed     Abstract available
    
    
    
19. KARSTENSEN JG, Novovic S, Schmidt PN
    Tailoring treatment to the circumstance: reasoning behind metal versus plastic drainage of pancreatic collections - authors' reply.
    Gut. 2023 Sep 12:gutjnl-2023-330948. doi: 10.1136/gutjnl-2023-330948.
    PubMed    
    
    
    August 2023
20. LIU X, Tang R, Xu J, Tan Z, et al
    CRIP1 fosters MDSC trafficking and resets tumour microenvironment via facilitating NF-kappaB/p65 nuclear translocation in pancreatic ductal adenocarcinoma.
    Gut. 2023 Aug 4:gutjnl-2022-329349. doi: 10.1136/gutjnl-2022-329349.
    PubMed     Abstract available
    
    
    July 2023
21. VANELLA G, Bronswijk M, Van der Merwe SW, Arcidiacono PG, et al
    Tailoring treatment to the circumstance: reasoning behind metal versus plastic drainage of pancreatic collections.
    Gut. 2023 Jul 31:gutjnl-2023-330442. doi: 10.1136/gutjnl-2023-330442.
    PubMed    
    
    
    June 2023
22. BLANCO-GOMEZ A, Jorgensen C
    FAK scaffolds immune escape in pancreatic cancer.
    Gut. 2023 Jun 6:gutjnl-2023-330049. doi: 10.1136/gutjnl-2023-330049.
    PubMed    
    
    
    
23. SAMANTA J, Dhar J
    Plastic is as good as metal: is the 'debris clearance' debate for walled-off necrosis drainage finally over?
    Gut. 2023;72:1223-1224.
    PubMed    
    
    
    May 2023
24. KINKER GS, Vitiello GAF, Diniz AB, Cabral-Piccin MP, et al
    Mature tertiary lymphoid structures are key niches of tumour-specific immune responses in pancreatic ductal adenocarcinomas.
    Gut. 2023 May 25:gutjnl-2022-328697. doi: 10.1136/gutjnl-2022-328697.
    PubMed     Abstract available
    
    
    April 2023
25. ZORNIAK M, Sirtl S, Beyer G, Mahajan UM, et al
    Consensus definition of sludge and microlithiasis as a possible cause of pancreatitis.
    Gut. 2023 Apr 18:gutjnl-2022-327955. doi: 10.1136/gutjnl-2022-327955.
    PubMed     Abstract available
    
    
    
26. BANG JY, Jhala N, Seth A, Krall K, et al
    Standardisation of EUS-guided FNB technique for molecular profiling in pancreatic cancer: results of a randomised trial.
    Gut. 2023 Apr 11:gutjnl-2023-329495. doi: 10.1136/gutjnl-2023-329495.
    PubMed    
    
    
    
27. RAPETTI-MAUSS R, Nigri J, Berenguier C, Finetti P, et al
    SK2 channels set a signalling hub bolstering CAF-triggered tumourigenic processes in pancreatic cancer.
    Gut. 2023;72:722-735.
    PubMed     Abstract available
    
    
    March 2023
28. CANEL M, Slawinska AD, Lonergan DW, Kallor AA, et al
    FAK suppresses antigen processing and presentation to promote immune evasion in pancreatic cancer.
    Gut. 2023 Mar 28:gutjnl-2022-327927. doi: 10.1136/gutjnl-2022-327927.
    PubMed     Abstract available
    
    
    
29. HAMDAN FH, Abdelrahman AM, Kutschat AP, Wang X, et al
    Interactive enhancer hubs (iHUBs) mediate transcriptional reprogramming and adaptive resistance in pancreatic cancer.
    Gut. 2023 Mar 8:gutjnl-2022-328154. doi: 10.1136/gutjnl-2022-328154.
    PubMed     Abstract available
    
    
    February 2023
30. HALLENSLEBEN ND, Stassen PMC, Schepers NJ, Besselink MG, et al
    Patient selection for urgent endoscopic retrograde cholangio-pancreatography by endoscopic ultrasound in predicted severe acute biliary pancreatitis (APEC-2): a multicentre prospective study.
    Gut. 2023 Feb 27:gutjnl-2022-328258. doi: 10.1136/gutjnl-2022-328258.
    PubMed     Abstract available
    
    
    
31. LIU J, Bai W, Zhou T, Xie Y, et al
    SDCBP promotes pancreatic cancer progression by preventing YAP1 from beta-TrCP-mediated proteasomal degradation.
    Gut. 2023 Feb 24:gutjnl-2022-327492. doi: 10.1136/gutjnl-2022-327492.
    PubMed     Abstract available
    
    
    
32. BEYER G, Kasprowicz F, Hannemann A, Aghdassi A, et al
    Definition of age-dependent reference values for the diameter of the common bile duct and pancreatic duct on MRCP: a population-based, cross-sectional cohort study.
    Gut. 2023 Feb 24:gutjnl-2021-326106. doi: 10.1136/gutjnl-2021-326106.
    PubMed     Abstract available
    
    
    
33. KARAMITOPOULOU E, Wenning AS, Acharjee A, Zlobec I, et al
    Spatially restricted tumour-associated and host-associated immune drivers correlate with the recurrence sites of pancreatic cancer.
    Gut. 2023 Feb 15:gutjnl-2022-329371. doi: 10.1136/gutjnl-2022-329371.
    PubMed     Abstract available
    
    
    January 2023
34. ZHU G, Wilhelm SJ, George LG, Cassidy BM, et al
    Preclinical mouse model of a misfolded PNLIP variant develops chronic pancreatitis.
    Gut. 2023 Jan 11:gutjnl-2022-327960. doi: 10.1136/gutjnl-2022-327960.
    PubMed     Abstract available
    
    
    
35. GLAUBITZ J, Wilden A, Frost F, Ameling S, et al
    Activated regulatory T-cells promote duodenal bacterial translocation into necrotic areas in severe acute pancreatitis.
    Gut. 2023 Jan 11:gutjnl-2022-327448. doi: 10.1136/gutjnl-2022-327448.
    PubMed     Abstract available
    
    
    
36. LOU H, Xie B, Wang Y, Gao Y, et al
    Improved NGS variant calling tool for the PRSS1-PRSS2 locus.
    Gut. 2023;72:210-212.
    PubMed    
    
    
    November 2022
37. KARSTENSEN JG, Novovic S, Hansen EF, Jensen AB, et al
    EUS-guided drainage of large walled-off pancreatic necroses using plastic versus lumen-apposing metal stents: a single-centre randomised controlled trial.
    Gut. 2022 Nov 29:gutjnl-2022-328225. doi: 10.1136/gutjnl-2022-328225.
    PubMed     Abstract available
    
    
    October 2022
38. BOXHOORN L, Verdonk RC, Voermans RP
    Response to letter to the editor: lumen-apposing metal stents versus double-pigtail plastic stents for infected necrotising pancreatitis.
    Gut. 2022 Oct 13. pii: gutjnl-2022-328686. doi: 10.1136/gutjnl-2022-328686.
    PubMed    
    
    
    September 2022
39. DE ANDRES MP, Jackson RJ, Felipe I, Zagorac S, et al
    GATA4 and GATA6 loss-of-expression is associated with extinction of the classical programme and poor outcome in pancreatic ductal adenocarcinoma.
    Gut. 2022 Sep 15. pii: gutjnl-2021-325803. doi: 10.1136/gutjnl-2021-325803.
    PubMed     Abstract available
    
    
    August 2022
40. TIWARI A, Shah A, Singh J
    LAMS versus plastic stents for infected pancreatic walled off necrosis (WON): has the addition of the TENSION trial to the AXIOMA study eased the tension?
    Gut. 2022 Aug 17. pii: gutjnl-2022-328148. doi: 10.1136/gutjnl-2022-328148.
    PubMed    
    
    
    
41. LIFFERS ST, Godfrey L, Frohn L, Haeberle L, et al
    Molecular heterogeneity and commonalities in pancreatic cancer precursors with gastric and intestinal phenotype.
    Gut. 2022 Aug 9. pii: gutjnl-2021-326550. doi: 10.1136/gutjnl-2021-326550.
    PubMed     Abstract available
    
    
    July 2022
42. LARGHI A, Facciorusso A
    Lumen-apposing metal stents versus double-pigtail plastic stents for infected necrotising pancreatitis: more doubts than answers.
    Gut. 2022 Jul 1. pii: gutjnl-2022-328149. doi: 10.1136/gutjnl-2022-328149.
    PubMed    
    
    
    June 2022
43. TAN PS, Garriga C, Clift A, Liao W, et al
    Temporality of body mass index, blood tests, comorbidities and medication use as early markers for pancreatic ductal adenocarcinoma (PDAC): a nested case-control study.
    Gut. 2022 Jun 27. pii: gutjnl-2021-326522. doi: 10.1136/gutjnl-2021-326522.
    PubMed     Abstract available
    
    
    
44. BOXHOORN L, Verdonk RC, Besselink MG, Boermeester M, et al
    Comparison of lumen-apposing metal stents versus double-pigtail plastic stents for infected necrotising pancreatitis.
    Gut. 2022 Jun 14. pii: gutjnl-2021-325632. doi: 10.1136/gutjnl-2021-325632.
    PubMed     Abstract available
    
    
    
45. WANG L, Liu Y, Dai Y, Tang X, et al
    Single-cell RNA-seq analysis reveals BHLHE40-driven pro-tumour neutrophils with hyperactivated glycolysis in pancreatic tumour microenvironment.
    Gut. 2022 Jun 10. pii: gutjnl-2021-326070. doi: 10.1136/gutjnl-2021-326070.
    PubMed     Abstract available
    
    
    May 2022
46. DE SANTIS MC, Gozzelino L, Margaria JP, Costamagna A, et al
    Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer.
    Gut. 2022 May 27. pii: gutjnl-2021-325117. doi: 10.1136/gutjnl-2021-325117.
    PubMed     Abstract available
    
    
    
47. JANCSO Z, Demcsak A, Sahin-Toth M
    Modelling chronic pancreatitis as a complex genetic disease in mice.
    Gut. 2022 May 16. pii: gutjnl-2022-327601. doi: 10.1136/gutjnl-2022-327601.
    PubMed    
    
    
    
48. ALFARANO G, Audano M, Di Chiaro P, Balestrieri C, et al
    Interferon regulatory factor 1 (IRF1) controls the metabolic programmes of low-grade pancreatic cancer cells.
    Gut. 2022 May 13. pii: gutjnl-2021-325811. doi: 10.1136/gutjnl-2021-325811.
    PubMed     Abstract available
    
    
    April 2022
49. YANG X, Yao L, Dai L, Yuan M, et al
    Alcohol predisposes obese mice to acute pancreatitis via adipose triglyceride lipase-dependent visceral adipocyte lipolysis.
    Gut. 2022 Apr 22. pii: gutjnl-2022-326958. doi: 10.1136/gutjnl-2022-326958.
    PubMed    
    
    
    
50. ALONSO-NOCELO M, Ruiz-Canas L, Sancho P, Gorgulu K, et al
    Macrophages direct cancer cells through a LOXL2-mediated metastatic cascade in pancreatic ductal adenocarcinoma.
    Gut. 2022 Apr 15. pii: gutjnl-2021-325564. doi: 10.1136/gutjnl-2021-325564.
    PubMed     Abstract available
    
    
    
51. COFFELT SB, Morton JP
    LOXL2 in pancreatic tumourigenesis: the complexity of tumour-stromal crosstalk exemplified.
    Gut. 2022 Apr 15. pii: gutjnl-2022-327430. doi: 10.1136/gutjnl-2022-327430.
    PubMed    
    
    
    
52. 
    Correction: Localisation of PGK1 determines metabolic phenotype to balance metastasis and proliferation in patients with SMAD4-negative pancreatic cancer.
    Gut. 2022;71:e5.
    PubMed    
    
    
    March 2022
53. KARTAL E, Schmidt TSB, Molina-Montes E, Rodriguez-Perales S, et al
    A faecal microbiota signature with high specificity for pancreatic cancer.
    Gut. 2022 Mar 8. pii: gutjnl-2021-324755. doi: 10.1136/gutjnl-2021-324755.
    PubMed     Abstract available
    
    
    
54. NEWSOME R, Jobin C
    Finding clues in unexpected places: detection of pancreatic cancer through the faecal microbiome.
    Gut. 2022 Mar 8. pii: gutjnl-2021-326710. doi: 10.1136/gutjnl-2021-326710.
    PubMed    
    
    
    
55. HE Z, Zhao S, Wang S, Song S, et al
    Rare cause of recurrent acute pancreatitis: a double whammy from the pancreas and duodenum.
    Gut. 2022 Mar 4. pii: gutjnl-2021-326704. doi: 10.1136/gutjnl-2021-326704.
    PubMed    
    
    
    February 2022
56. NAYAR M, Leeds JS, Oppong K
    Lumen-apposing metal stents for drainage of pancreatic fluid collections: does timing of removal matter?
    Gut. 2022 Feb 25. pii: gutjnl-2021-325812. doi: 10.1136/gutjnl-2021-325812.
    PubMed    
    
    
    
57. AMATO A, Tarantino I, Facciorusso A, Binda C, et al
    Real-life multicentre study of lumen-apposing metal stent for EUS-guided drainage of pancreatic fluid collections.
    Gut. 2022 Feb 22. pii: gutjnl-2022-326880. doi: 10.1136/gutjnl-2022-326880.
    PubMed    
    
    
    January 2022
58. KUMAR S, Schoonderwoerd MJA, Kroonen JS, de Graaf IJ, et al
    Targeting pancreatic cancer by TAK-981: a SUMOylation inhibitor that activates the immune system and blocks cancer cell cycle progression in a preclinical model.
    Gut. 2022 Jan 24. pii: gutjnl-2021-324834. doi: 10.1136/gutjnl-2021-324834.
    PubMed     Abstract available
    
    
    
59. VARGHESE C, Nayar M, Pandanaboyana S
    SARS-CoV-2 pandemic has impacted on patterns of aetiology for acute pancreatitis and management of gallstone pancreatitis in the UK.
    Gut. 2022 Jan 17. pii: gutjnl-2021-326845. doi: 10.1136/gutjnl-2021-326845.
    PubMed    
    
    
    
60. BELLOMO G, Rainer C, Quaranta V, Astuti Y, et al
    Chemotherapy-induced infiltration of neutrophils promotes pancreatic cancer metastasis via Gas6/AXL signalling axis.
    Gut. 2022 Jan 12. pii: gutjnl-2021-325272. doi: 10.1136/gutjnl-2021-325272.
    PubMed     Abstract available
    
    
    
61. RUIVO CF, Bastos N, Adem B, Batista I, et al
    Extracellular Vesicles from Pancreatic Cancer Stem Cells Lead an Intratumor Communication Network (EVNet) to fuel tumour progression.
    Gut. 2022 Jan 10. pii: gutjnl-2021-324994. doi: 10.1136/gutjnl-2021-324994.
    PubMed     Abstract available
    
    
    
62. WANG YC, Mao XT, Yu D, Mao SH, et al
    Alcohol amplifies the association between common variants at PRSS1-PRSS2 locus and chronic pancreatitis in a dose-dependent manner.
    Gut. 2022 Jan 7. pii: gutjnl-2021-326670. doi: 10.1136/gutjnl-2021-326670.
    PubMed    
    
    
    December 2021
63. HUANG HC, Sung YC, Li CP, Wan D, et al
    Reversal of pancreatic desmoplasia by a tumour stroma-targeted nitric oxide nanogel overcomes TRAIL resistance in pancreatic tumours.
    Gut. 2021 Dec 17. pii: gutjnl-2021-325180. doi: 10.1136/gutjnl-2021-325180.
    PubMed     Abstract available
    
    
    
64. ROSENDAHL J
    Understanding pain in chronic pancreatitis: not yet the end of the story?
    Gut. 2021 Dec 9. pii: gutjnl-2021-326279. doi: 10.1136/gutjnl-2021-326279.
    PubMed    
    
    
    November 2021
65. NAYAR M, Varghese C, Kanwar A, Siriwardena AK, et al
    SARS-CoV-2 infection is associated with an increased risk of idiopathic acute pancreatitis but not pancreatic exocrine insufficiency or diabetes: long-term results of the COVIDPAN study.
    Gut. 2021 Nov 11. pii: gutjnl-2021-326218. doi: 10.1136/gutjnl-2021-326218.
    PubMed    
    
    
    
66. BENITZ S, Crawford H
    Discovery of the pancreatic basal cell: a new candidate for an adult stem cell emerges.
    Gut. 2021 Nov 3. pii: gutjnl-2021-325694. doi: 10.1136/gutjnl-2021-325694.
    PubMed    
    
    
    
67. EROSS B, Szentesi A, Hegyi P
    Metabolic signature might be an option to identify patients with early CP.
    Gut. 2021;70:2023-2024.
    PubMed    
    
    
    October 2021
68. LEE B, Namkoong H, Yang Y, Huang H, et al
    Single-cell sequencing unveils distinct immune microenvironments with CCR6-CCL20 crosstalk in human chronic pancreatitis.
    Gut. 2021 Oct 26. pii: gutjnl-2021-324546. doi: 10.1136/gutjnl-2021-324546.
    PubMed     Abstract available
    
    
    
69. CABASAG CJ, Ferlay J, Laversanne M, Vignat J, et al
    Pancreatic cancer: an increasing global public health concern.
    Gut. 2021 Oct 22. pii: gutjnl-2021-326311. doi: 10.1136/gutjnl-2021-326311.
    PubMed    
    
    
    
70. OLESEN SS, Phillips AE, Faghih M, Kuhlmann L, et al
    Overlap and cumulative effects of pancreatic duct obstruction, abnormal pain processing and psychological distress on patient-reported outcomes in chronic pancreatitis.
    Gut. 2021 Oct 21. pii: gutjnl-2021-325855. doi: 10.1136/gutjnl-2021-325855.
    PubMed     Abstract available
    
    
    
71. YANG F, Huang Y, Li T, Fu Y, et al
    Prevalence and outcomes of acute pancreatitis in COVID-19: a meta-analysis.
    Gut. 2021 Oct 20. pii: gutjnl-2021-325941. doi: 10.1136/gutjnl-2021-325941.
    PubMed    
    
    
    
72. KRYKLYVA V, Luchini C, Stommel MWJ, Nagtegaal ID, et al
    Detecting Lynch syndrome in pancreatic ductal adenocarcinoma FNA cytology based on cancer history and immunocytochemistry.
    Gut. 2021 Oct 19. pii: gutjnl-2021-326033. doi: 10.1136/gutjnl-2021-326033.
    PubMed    
    
    
    July 2021
73. MARTENS S, Coolens K, Van Bulck M, Arsenijevic T, et al
    Discovery and 3D imaging of a novel DeltaNp63-expressing basal cell type in human pancreatic ducts with implications in disease.
    Gut. 2021 Jul 30. pii: gutjnl-2020-322874. doi: 10.1136/gutjnl-2020-322874.
    PubMed     Abstract available
    
    
    
74. HALLENSLEBEN ND, Timmerhuis HC, Hollemans RA, Pocornie S, et al
    Optimal timing of cholecystectomy after necrotising biliary pancreatitis.
    Gut. 2021 Jul 16. pii: gutjnl-2021-324239. doi: 10.1136/gutjnl-2021-324239.
    PubMed     Abstract available
    
    
    June 2021
75. POTJER TP
    Pancreatic cancer surveillance and its ongoing challenges: is it time to refine our eligibility criteria?
    Gut. 2021 Jun 18. pii: gutjnl-2021-324739. doi: 10.1136/gutjnl-2021-324739.
    PubMed    
    
    
    
76. LV XH, Deng K, Yang JL
    Duality of the association between COVID-19 and acute pancreatitis.
    Gut. 2021 Jun 15. pii: gutjnl-2021-325221. doi: 10.1136/gutjnl-2021-325221.
    PubMed    
    
    
    May 2021
77. KOSCHNY R, Lang M, Hackert T
    Enormously dilated pancreatic duct.
    Gut. 2021 May 7. pii: gutjnl-2021-324335. doi: 10.1136/gutjnl-2021-324335.
    PubMed    
    
    
    
78. GENIN E, Cooper DN, Masson E, Ferec C, et al
    NGS mismapping confounds the clinical interpretation of the PRSS1 p.Ala16Val (c.47C>T) variant in chronic pancreatitis.
    Gut. 2021 May 7. pii: gutjnl-2021-324943. doi: 10.1136/gutjnl-2021-324943.
    PubMed    
    
    
    April 2021
79. CHANDRA V, McAllister F
    Therapeutic potential of microbial modulation in pancreatic cancer.
    Gut. 2021 Apr 27. pii: gutjnl-2019-319807. doi: 10.1136/gutjnl-2019-319807.
    PubMed    
    
    
    
80. HACKENG WM, Brosens LAA, Kim JY, O'Sullivan R, et al
    Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size.
    Gut. 2021 Apr 13. pii: gutjnl-2020-322595. doi: 10.1136/gutjnl-2020-322595.
    PubMed     Abstract available
    
    
    
81. KLOESCH B, Ionasz V, Paliwal S, Hruschka N, et al
    A GATA6-centred gene regulatory network involving HNFs and DeltaNp63 controls plasticity and immune escape in pancreatic cancer.
    Gut. 2021 Apr 12. pii: gutjnl-2020-321397. doi: 10.1136/gutjnl-2020-321397.
    PubMed     Abstract available
    
    
    
82. XIE Z, Gao Y, Ho C, Li L, et al
    Exosome-delivered CD44v6/C1QBP complex drives pancreatic cancer liver metastasis by promoting fibrotic liver microenvironment.
    Gut. 2021 Apr 7. pii: gutjnl-2020-323014. doi: 10.1136/gutjnl-2020-323014.
    PubMed     Abstract available
    
    
    
83. OVERBEEK KA, Levink IJM, Koopmann BDM, Harinck F, et al
    Long-term yield of pancreatic cancer surveillance in high-risk individuals.
    Gut. 2021 Apr 5. pii: gutjnl-2020-323611. doi: 10.1136/gutjnl-2020-323611.
    PubMed     Abstract available
    
    
    March 2021
84. GLEESON FC, Jeraldo P, Levy MJ, Murphy SJ, et al
    Composition, diversity and potential utility of intervention-naive pancreatic cancer intratumoral microbiome signature profiling via endoscopic ultrasound.
    Gut. 2021 Mar 22. pii: gutjnl-2021-324031. doi: 10.1136/gutjnl-2021-324031.
    PubMed    
    
    
    
85. ZHOU T, Liu J, Xie Y, Yuan S, et al
    ESE3/EHF, a promising target of rosiglitazone, suppresses pancreatic cancer stemness by downregulating CXCR4.
    Gut. 2021 Mar 5. pii: gutjnl-2020-321952. doi: 10.1136/gutjnl-2020-321952.
    PubMed     Abstract available
    
    
    
86. KOLODKIN-GAL D, Roitman L, Ovadya Y, Azazmeh N, et al
    Senolytic elimination of Cox2-expressing senescent cells inhibits the growth of premalignant pancreatic lesions.
    Gut. 2021 Mar 1. pii: gutjnl-2020-321112. doi: 10.1136/gutjnl-2020-321112.
    PubMed     Abstract available
    
    
    February 2021
87. TACELLI M, Zaccari P, Capurso G, Arcidiacono PG, et al
    Artificial intelligence in EUS for autoimmune pancreatitis: bias and real life.
    Gut. 2021 Feb 22. pii: gutjnl-2021-324338. doi: 10.1136/gutjnl-2021-324338.
    PubMed    
    
    
    
88. SUN X, He X, Zhang Y, Hosaka K, et al
    Inflammatory cell-derived CXCL3 promotes pancreatic cancer metastasis through a novel myofibroblast-hijacked cancer escape mechanism.
    Gut. 2021 Feb 10. pii: gutjnl-2020-322744. doi: 10.1136/gutjnl-2020-322744.
    PubMed     Abstract available
    
    
    
89. PANDANABOYANA S, Moir J, Leeds JS, Oppong K, et al
    SARS-CoV-2 infection in acute pancreatitis increases disease severity and 30-day mortality: COVID PAN collaborative study.
    Gut. 2021 Feb 5. pii: gutjnl-2020-323364. doi: 10.1136/gutjnl-2020-323364.
    PubMed     Abstract available
    
    
    
90. ADAM MG, Beyer G, Christiansen N, Kamlage B, et al
    Identification and validation of a multivariable prediction model based on blood plasma and serum metabolomics for the distinction of chronic pancreatitis subjects from non-pancreas disease control subjects.
    Gut. 2021 Feb 4. pii: gutjnl-2020-320723. doi: 10.1136/gutjnl-2020-320723.
    PubMed     Abstract available
    
    
    January 2021
91. LUCHINI C, Grant RC, Scarpa A, Gallinger S, et al
    Microsatellite instability/mismatch repair deficiency in pancreatic cancers: the same or different?
    Gut. 2021 Jan 19. pii: gutjnl-2020-323805. doi: 10.1136/gutjnl-2020-323805.
    PubMed    
    
    
    November 2020
92. RANA SS, Gupta R
    Walled of necrosis, disconnected pancreatic duct and metal stents: the debate continues!
    Gut. 2020 Nov 9. pii: gutjnl-2020-323190. doi: 10.1136/gutjnl-2020-323190.
    PubMed    
    
    
    
93. FROST F, Kacprowski T, Ruhlemann M, Pietzner M, et al
    Long-term instability of the intestinal microbiome is associated with metabolic liver disease, low microbiota diversity, diabetes mellitus and impaired exocrine pancreatic function.
    Gut. 2020 Nov 9. pii: gutjnl-2020-322753. doi: 10.1136/gutjnl-2020-322753.
    PubMed     Abstract available
    
    
    
94. KEMPENEERS MA, Issa Y, Verdonk RC, Bruno M, et al
    Pain patterns in chronic pancreatitis: a nationwide longitudinal cohort study.
    Gut. 2020 Nov 6. pii: gutjnl-2020-322117. doi: 10.1136/gutjnl-2020-322117.
    PubMed     Abstract available
    
    
    October 2020
95. SANO M, Takahashi R, Ijichi H, Ishigaki K, et al
    Blocking VCAM-1 inhibits pancreatic tumour progression and cancer-associated thrombosis/thromboembolism.
    Gut. 2020 Oct 21. pii: gutjnl-2020-320608. doi: 10.1136/gutjnl-2020-320608.
    PubMed     Abstract available
    
    
    
96. MARYA NB, Powers PD, Chari ST, Gleeson FC, et al
    Utilisation of artificial intelligence for the development of an EUS-convolutional neural network model trained to enhance the diagnosis of autoimmune pancreatitis.
    Gut. 2020 Oct 7. pii: gutjnl-2020-322821. doi: 10.1136/gutjnl-2020-322821.
    PubMed     Abstract available
    
    
    
97. DIAFERIA GR, Natoli G
    Transcription factors as drivers of distinct pancreatic ductal adenocarcinoma (PDAC) programmes: a role for HNF4A.
    Gut. 2020 Oct 1. pii: gutjnl-2020-322814. doi: 10.1136/gutjnl-2020-322814.
    PubMed    
    
    
    September 2020
98. WEISS FU, Laemmerhirt F, Lerch MM
    Next generation sequencing pitfalls in diagnosing trypsinogen (PRSS1) mutations in chronic pancreatitis.
    Gut. 2020 Sep 28. pii: gutjnl-2020-322864. doi: 10.1136/gutjnl-2020-322864.
    PubMed    
    
    
    
99. BARRETO SG, Habtezion A, Gukovskaya A, Lugea A, et al
    Critical thresholds: key to unlocking the door to the prevention and specific treatments for acute pancreatitis.
    Gut. 2020 Sep 24. pii: gutjnl-2020-322163. doi: 10.1136/gutjnl-2020-322163.
    PubMed     Abstract available
    
    
    April 2020
100. HU Q, Wu J, Ren Y, Wu X, et al
     Degree of STING activation is associated with disease outcomes.
     Gut. 2020;69:792-794.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Pancreatitis is free of charge.